Christopher Storey, MD
Neurological Surgery · Hermitage, TNNPI 1811289135
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 62.4% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2023 at $26,500 and has fallen 88.8% since, to $2,955 in 2025.
Across 314 payments — averaging $186.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$37K
- Microvention, Inc.$10K
- Ischemaview, Inc.$3K
- Abbott$2K
- Globus Medical$2K
- Medical Device Business Services, Inc.$1K
- plus $4K from 34 others
Across 12 payments — averaging $2525.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$30K
Across 3 payments — averaging $119,313 each. An ownership or investment interest held by the physician or an immediate family member.
- Vesalio, Inc.$358K
What the payments were for
- Consulting fees$11,39019%
- Speaking & faculty fees$31,21553%
- Travel & lodging$7,37713%
- Food & beverage$8,68715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 52 | $36,585 |
| Microvention, Inc. | 16 | $9,543 |
| Ischemaview, Inc. | 3 | $3,100 |
| Abbott | 111 | $2,319 |
| Globus Medical | 17 | $1,665 |
| Medical Device Business Services, Inc. | 1 | $1,160 |
| Johnson & Johnson(2 entities) | 20 | $689 |
| Nevro Corp. | 15 | $536 |
| Boston Scientific | 15 | $454 |
| Penumbra, Inc. | 4 | $446 |
| Stryker | 9 | $298 |
| Biocomposites Inc | 3 | $216 |
| Silk Road Medical, Inc. | 1 | $199 |
| Imperative Care, Inc | 5 | $180 |
| Highridge Medical LLC | 2 | $180 |
| Scientia Vascular | 2 | $155 |
| Zimvie Inc. | 1 | $140 |
| EBI, LLC | 1 | $90 |
| Kls-martin L.p. | 3 | $58 |
| AstraZeneca(2 entities) | 3 | $57 |
| Si-bone, Inc. | 3 | $55 |
| Orthofix Medical, Inc. | 3 | $52 |
| Integra Lifesciences Corporation | 2 | $51 |
| Baxter Healthcare | 2 | $48 |
| DJO, LLC | 2 | $42 |
| Route 92 Medical, Inc. | 2 | $39 |
| Novocure Inc. | 1 | $39 |
| Portola Pharmaceuticals, LLC | 2 | $36 |
| Intrinsic Therapeutics | 1 | $30 |
| Saluda Medical Americas, Inc. | 1 | $28 |
| Elevation Spine, Inc. | 1 | $23 |
| Spineology Inc. | 2 | $23 |
| Smith+Nephew | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Aesculap, Inc. | 1 | $19 |
| Siemens Medical Solutions USA, Inc. | 1 | $18 |
| NICO Corporation | 1 | $16 |
| Brainlab, Inc. | 1 | $15 |
| Mizuho America, Inc. | 1 | $12 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RIST$13,920
- Rist-5F$7,175
- WEB Aneurysm Embolization System$7,142
- Axium$2,900
- SOLITAIRE X$1,939
- WEB$1,314
- EMBOGUARD$1,160
- Pipeline$927
- O-ARM-ST$631
- Excelsius - GPS$626
- Penumbra System$499
- Excelsius Robotics System$435
- AXIUM PRIMETM$435
- ENROUTE Transcarotid Neuroprotection System$398
- PROCLAIM$345
- Omnia$303
- Biomet SpinalPak Non-invasive Spine Fusion Stimulator System$300
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$199
- ENROUTE Transcarotid Stent$199
- Covidien-Intrasaccular$158
How this compares
$58,668 in reported general payments places this provider in the 85th percentile of 156 neurological surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 38 | $290 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Hermitage
- Christopher TaleghaniHermitage$93K
- Margaret MacgregorHermitage$30K
- Kevin FoleyMemphis$162.4M
- Maurice SmithMemphis$4.4M
- Brian OshaughnessyNashville$2.1M
- Adam ArthurMemphis$1.9M
- Paul ParkMemphis$1.2M
- Daniel HoitMemphis$607K
- David WilesChattanooga$315K
- Chine LoganNashville$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.